Peachtree Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Peachtree Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,150	Closed	-$379K	–	85
2016 Q2	$379K	Hold	5,150	–	–	0.39%	62
2016 Q1	$329K	Hold	5,150	–	–	0.33%	76
2015 Q4	$354K	Hold	5,150	–	–	0.37%	66
2015 Q3	$305K	Hold	5,150	–	–	0.32%	83
2015 Q2	$343K	Hold	5,150	–	–	0.26%	99
2015 Q1	$332K	Buy	5,150 +920	+22%	+$57.6K	0.24%	98
2014 Q4	$250K	Sell	4,230 -1,624	-28%	-$91.6K	0.17%	126
2014 Q3	$300K	Sell	5,854 -1,375	-19%	-$68.7K	0.2%	112
2014 Q2	$351K	Hold	7,229	–	–	0.23%	101
2014 Q1	$376K	Hold	7,229	–	–	0.26%	95
2013 Q4	$384K	Buy	+7,229	New	+$368K	0.26%	94

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Peachtree Investment Advisors's BMY Position: Q3 2016 in Review

Peachtree Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 5,150 shares — an estimated $379K sold.

Peachtree Investment Advisors first reported a position in BMY in Q4 2013 and held it in 11 quarters. The position peaked at $384K in Q4 2013. 1,523 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

Peachtree Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
Peachtree Investment Advisors sold 5,150 Bristol-Myers Squibb shares in Q3 2016, an estimated $379K.
Peachtree Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 11 quarters.
Peachtree Investment Advisors's Bristol-Myers Squibb position peaked at $384K in Q4 2013.
1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Peachtree Investment Advisors's 13F filing for Q3 2016, filed 6 Oct 2016.